Yongzhe Li Selected Research

7- O- (3- amino- 2,3,6- trideoxy- alpha- hexopyranosyl)- epsilon- isorhodomycinone (ATHR)

4/2017

Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongzhe Li Research Topics

Disease

14	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2022 - 06/2009
14	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 06/2009
13	COVID-19 12/2021 - 01/2020
11	Inflammation (Inflammations) 01/2022 - 07/2014
11	Rheumatoid Arthritis 05/2021 - 01/2010
8	Immunoglobulin G4-Related Disease 05/2022 - 05/2014
8	Dermatomyositis (Dermatopolymyositis) 01/2022 - 01/2014
7	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2020 - 11/2015
7	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2016 - 01/2010
6	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 04/2013
6	Takayasu Arteritis (Arteritis, Takayasu's) 12/2021 - 01/2017
6	Thrombosis (Thrombus) 10/2020 - 04/2016
5	Neoplasms (Cancer) 01/2022 - 01/2019
5	Polymyositis 01/2022 - 02/2016
5	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021 - 01/2014
5	Liver Diseases (Liver Disease) 01/2021 - 01/2010
5	Crohn Disease (Crohn's Disease) 10/2020 - 10/2015
4	Myositis (Idiopathic Inflammatory Myopathies) 03/2021 - 04/2017
4	Vasculitis (Vasculitides) 01/2021 - 03/2015
4	Ulcerative Colitis 10/2020 - 01/2015
4	Genetic Predisposition to Disease (Genetic Predisposition) 11/2018 - 05/2012
3	Sjogren's Syndrome (Sjogren Syndrome) 05/2022 - 01/2010
3	Glioma (Gliomas) 01/2022 - 11/2017
3	Behcet Syndrome (Behcet's Syndrome) 01/2021 - 01/2021
3	Connective Tissue Diseases (Connective Tissue Disease) 04/2020 - 01/2019
3	Lupus Nephritis 12/2016 - 03/2011
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 05/2017
2	Infections 12/2020 - 11/2020
2	Critical Illness (Critically Ill) 12/2020 - 10/2020
2	Cytokine Release Syndrome 11/2020 - 10/2020
2	Venous Thrombosis (Deep-Vein Thrombosis) 08/2019 - 01/2018
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2018 - 10/2015
2	Central Nervous System Lupus Vasculitis 01/2015 - 03/2011
2	Autoimmune Hepatitis 11/2011 - 01/2010
1	Retroperitoneal Fibrosis 05/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022
1	Cryoglobulinemia 01/2022
1	Coronary Disease (Coronary Heart Disease) 12/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 11/2021
1	Calcinosis 03/2021
1	Muscle Weakness 03/2021
1	Edema (Dropsy) 03/2021

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2009
22	AntibodiesIBA 01/2021 - 11/2011
18	Immunoglobulin G (IgG)IBA 05/2022 - 05/2014
15	AutoantibodiesIBA 03/2021 - 03/2011
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2009
8	Antiphospholipid AntibodiesIBA 12/2020 - 11/2015
5	Immunoglobulin M (IgM)IBA 01/2021 - 04/2017
5	CytokinesIBA 11/2020 - 05/2014
4	Peptides (Polypeptides)IBA 05/2021 - 01/2018
4	AutoantigensIBA 08/2020 - 01/2010
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 10/2015
3	ProteomeIBA 01/2021 - 01/2015
3	Prothrombin (Factor II)IBA 12/2020 - 04/2017
3	ImmunosorbentsIBA 12/2020 - 11/2013
3	Glycoproteins (Glycoprotein)IBA 12/2020 - 10/2015
3	EnzymesIBA 12/2020 - 11/2013
3	Immunoglobulin A (IgA)IBA 12/2020 - 04/2017
3	Blood Proteins (Serum Proteins)IBA 11/2020 - 06/2009
2	Indicators and Reagents (Reagents)IBA 05/2022 - 12/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 10/2020
2	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 01/2021
2	Phosphopyruvate Hydratase (Enolase)IBA 05/2021 - 01/2019
2	fibrin fragment D (D-dimer)IBA 02/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 02/2021 - 11/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 08/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 11/2015
2	EpitopesIBA 01/2021 - 12/2016
2	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2021 - 08/2019
2	PhosphatidylserinesIBA 12/2020 - 01/2018
2	LipidsIBA 12/2020 - 01/2016
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020 - 08/2019
2	HLA-B Antigens (HLA-B)IBA 01/2018 - 01/2017
2	mesoglycanIBA 01/2017 - 03/2015
2	Phosphotransferases (Kinase)IBA 01/2015 - 01/2015
2	I-kappa B KinaseIBA 01/2015 - 01/2015
2	cyclic citrullinated peptideIBA 01/2014 - 01/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2014
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Meloxicam (Mobic)FDA LinkGeneric 01/2022
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022
1	CryoglobulinsIBA 01/2022
1	ThrombomodulinIBA 12/2021
1	Syndecan-1 (Syndecan 1)IBA 12/2021
1	LDL CholesterolIBA 12/2021
1	Lipoprotein(a)IBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 11/2021
1	Mannose (D-Mannose)IBA 03/2021
1	Polysaccharides (Glycans)IBA 03/2021
1	nuclear matrix protein 2IBA 03/2021
1	FucoseIBA 03/2021

Therapy/Procedure

5	Therapeutics 01/2021 - 11/2017
3	Aftercare (After-Treatment) 08/2019 - 03/2011
3	Lasers (Laser) 10/2011 - 03/2011